Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Pilatus Biosciences

News headline image
Pilatus Biosciences Presents New Preclinical Data at SITC 2026 Demonstrating Potential of PLT012 to Overcome Immunotherapy Resistance in Liver Cancer
From Pilatus Biosciences
Via Business Wire
News headline image
Pilatus Biosciences Announces First Patient Dosed in Hong Kong Clinical Trial of PLT012 for Liver Cancer Expansion
From Pilatus Biosciences
Via Business Wire
News headline image
Pilatus Biosciences to Present Trials-in-Progress Poster on Phase 1 PLT012 for Solid Tumor Cancers at ESMO 2026
From Pilatus Biosciences
Via Business Wire
News headline image
Pilatus Biosciences Strengthens Global Intellectual Property Position for Lead CD36-Targeted Immunometabolic Therapy
From Pilatus Biosciences
Via Business Wire
News headline image
Pilatus Biosciences to Present New Preclinical Data Advancing PLT012 into COPD at the European Respiratory Society International Congress 2026
From Pilatus Biosciences
Via Business Wire
News headline image
Pilatus Biosciences Publishes Preclinical Data in Cancer Discovery on PLT012 First-in-Class CD36-Targeting Antibody for Liver Cancer
From Pilatus Biosciences
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.